Funding Opportunities

NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents. Scroll down for information and opportunities that may be of interest. Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts July 30, 2021   General Notices Updated Policy for Family Leave and Unpaid Leave for Extramural Loan Repayment Program Recipients (NOT-OD-21-153) Office of the Director, NIH Request for Information (RFI): Climate Change and Health (NOT-ES-21-009) National Institute of Environmental Health Sciences John E. Fogarty International Center National Cancer Institute Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Nursing Research Office of Research on Women's Health Notice of Changes to Funding Opportunities Notice of NIAMS Withdrawal from Participation inPAR-19-173 "Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed)" (NOT-AR-21-027) National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice of Correction to RFA-DA-22-031 HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) (NOT-DA-21-066) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice of Correction to RFA-DA-22-032, HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed). (NOT-DA-21-067) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice of Expiration of PAR-21-197, NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required). (NOT-DE-21-011) National Institute of Dental and Craniofacial Research Notice of Correction to Effort Requirements Identified in NOT-DK-21-018 for PAR-20-220: Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C Clinical Trial Not Allowed) (NOT-DK-21-026) National Institute of Diabetes and Digestive and Kidney Diseases Notice of Participation of NIEHS in PAR-21-248 "Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)" (NOT-ES-21-011) National Institute of Environmental Health Sciences Notice of Change in Expiration Date for PAR-21-280, "Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)" (NOT-OD-21-166) NIH Basic Behavioral and Social Science Opportunity Network Office of Behavioral and Social Sciences Research Notice to Terminate RFA-HG-21-025 "New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) (NOT-OD-21-171) National Institutes of Health Notices of Special Interest Notice of Special Interest (NOSI): Immune Responses to Arthropod Feeding on Vertebrate Hosts (NOT-AI-21-059) National Institute of Allergy and Infectious Diseases Notice of Special Interest (NOSI): Using the Collaborative Cross (CC) Mouse Model for Immunoregulatory and Infectious Disease Research (NOT-AI-21-071) National Institute of Allergy and Infectious Diseases Notice of Special Interest (NOSI): Short-term Mentored Research Career Enhancement Award to Promote Genomic Medicine Diversity (NOT-HG-21-039) National Human Genome Research Institute Notice of Special Interest: Administrative Supplements for RCMI Practice-Based Clinical Research Networks (NOT-MD-21-025) National Institute on Minority Health and Health Disparities Notice of Special Interest: Adding TBI Assessments to AD/ADRD Cohorts (NOT-NS-22-002) National Institute of Neurological Disorders and Stroke National Institute on Aging Funding Opportunities Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) (PAR-21-254) National Human Genome Research Institute Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is Oct 5,2021. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) (PAR-21-255) National Human Genome Research Institute Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is Oct 16, 2021. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed) (PAR-21-256) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): August 30, 2021, July 14, 2022, July 13, 2023 Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) (PAR-21-288) National Institute of Mental Health Application Receipt Date(s): Multiple dates, see announcement. Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) (PAR-21-289) National Institute of Mental Health Application Receipt Date(s): Multiple dates, see announcement. Clinical and Translational Science Award (UM1 Clinical Trial Optional) (PAR-21-293) National Center for Advancing Translational Sciences Application Receipt Date(s): Multiple dates, see announcement. Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed) (RFA-CA-21-041) National Cancer Institute Application Receipt Date(s): November 01, 2021 Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed) (RFA-CA-21-042) National Cancer Institute Application Receipt Date(s): November 01, 2021 Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) (RFA-CA-21-048) National Cancer Institute Application Receipt Date(s): November 12, 2021; October 19, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement. Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-CA-21-049) National Cancer Institute Application Receipt Date(s): November 12, 2021 Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) (RFA-CA-21-050) National Cancer Institute Application Receipt Date(s): September 27, 2021 Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed) (RFA-CA-21-051) National Cancer Institute Application Receipt Date(s): September 27, 2021 Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed) (RFA-DA-22-018) National Institute on Drug Abuse Application Receipt Date(s): February 18, 2022 No late applications will be accepted for this Funding Opportunity Announcement. Advancing Validated Drug Targets for Substance Use Disorders (R43/R44 - Clinical Trial Not Allowed) (RFA-DA-22-023) National Institute on Drug Abuse Application Receipt Date(s): February 18, 2022 No late applications will be accepted for this Funding Opportunity Announcement. Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required) (RFA-DK-21-018) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): March 03, 2022 BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed) (RFA-MH-21-235) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date(s): November 09, 2021 BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed) (RFA-MH-21-236) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date(s): November 09, 2021 BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed) (RFA-MH-21-237) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date(s): November 09, 2021 Creating an Educational Nexus for Training in Experimental Rigor (CENTER) (UC2 Clinical Trial Not Allowed) (RFA-NS-21-009) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): October 21, 2021 Materials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed) (RFA-NS-21-033) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): October 21, 2021 October 11, 2022 October 10, 2023   NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format - click here for details. To UnSubscribe to the NIH Guide Weekly TOC LISTSERV, follow the instructions here. This weekly list can be found here. To join or leave the NIBIB Listserv, please visit this webpage and complete the online form. You can also change your options for the Listserv at this site.

HOME  |  DISCLAIMER  |  POLICIES  |  ACCESSIBILITY  |  FOIA  |  NEWS  |  CONTACT US

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute for Biomedical Imaging and Bioengineering · 9000 Rockville Pike, Building 31, Room 1C14, Bethesda, MD 20892